Minocycline for the management of multiple sclerosis: repositioning potential, opportunities, and challenges.

Chauhan, Prerna; Kakkar, Ashish Kumar; Singh, Harmanjit; Gautam, C S

Chauhan, Prerna; Kakkar, Ashish Kumar; Singh, Harmanjit; Gautam, C S.

Afiliación

Chauhan P; Department of Pharmacology, All India Institute of Medical Sciences , New Delhi, India.
Kakkar AK; Department of Pharmacology, Postgraduate Institute of Medical Education and Research , Chandigarh, India.
Singh H; Department of Pharmacology, Government Medical College and Hospital , Chandigarh, India.
Gautam CS; Department of Pharmacology, Government Medical College and Hospital , Chandigarh, India.

Expert Rev Neurother ; 21(1): 35-43, 2021 01.

Article en En | MEDLINE | ID: mdl-33059513

Asunto(s)

Minociclina; Esclerosis Múltiple; Reposicionamiento de Medicamentos; Humanos; Inmunomodulación; Minociclina/uso terapéutico; Esclerosis Múltiple/tratamiento farmacológico

Palabras clave

Autoimmune; RRMS; adverse effects; clinically isolated syndrome; demyelination; neurodegenerative; repositioning; safety

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Minociclina / Esclerosis Múltiple Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Expert Rev Neurother Asunto de la revista: NEUROLOGIA / TERAPEUTICA Año: 2021 Tipo del documento: Article País de afiliación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google